Ilumetri 100 mg solution for injection in pre-filled syringe *
Pharmacy Only: Prescription

  • Company:

    Almirall Limited
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 09 August 2022

File name

62f2716f54024.pdf

Reasons for updating

  • Addition of joint SPC covering all presentations

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Updated with new additional presentation of 200 mg/2 ml solution for injection in pre-filled syringe. MAH number: EU/1?18/1323/003.

Section 4.8 updated: Immunogenicity - cases of neutralising antibodies in 7.3% of patients treated with tildrakizumab.

Updated on 23 June 2021

File name

PIL Ilumetri 100mg PFS NSD GB_IE 80018954_1624446436.pdf

Reasons for updating

  • New PIL for new product

Free text change information supplied by the pharmaceutical company

update of address of manufacturing site in Barcelona, Spain

Updated on 31 January 2020

File name

uk-ie-smpc-ilumetri_1580486115.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)